ROK vs TOVX · P/E 48, rev $8.34B vs rev $300.0K
Rockwell Automation Inc (ROK) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
ROK currently screens at market cap $51.04B and trailing P/E 47.5. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the ROK and TOVX stock pages for the full models.
Not investment advice.